338 related articles for article (PubMed ID: 12796197)
21. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
22. Application of low-temperature glassy carbon-coated macrofibers for solid-phase microextraction analysis of simulated breath volatiles.
Giardina M; Olesik SV
Anal Chem; 2003 Apr; 75(7):1604-14. PubMed ID: 12705592
[TBL] [Abstract][Full Text] [Related]
23. Point-of-care breath test for biomarkers of active pulmonary tuberculosis.
Phillips M; Basa-Dalay V; Blais J; Bothamley G; Chaturvedi A; Modi KD; Pandya M; Natividad MP; Patel U; Ramraje NN; Schmitt P; Udwadia ZF
Tuberculosis (Edinb); 2012 Jul; 92(4):314-20. PubMed ID: 22647661
[TBL] [Abstract][Full Text] [Related]
24. Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer.
Mazzone PJ
J Thorac Oncol; 2008 Jul; 3(7):774-80. PubMed ID: 18594325
[TBL] [Abstract][Full Text] [Related]
25. Increased breath biomarkers of oxidative stress in diabetes mellitus.
Phillips M; Cataneo RN; Cheema T; Greenberg J
Clin Chim Acta; 2004 Jun; 344(1-2):189-94. PubMed ID: 15149888
[TBL] [Abstract][Full Text] [Related]
26. Application of an artificial neural network model for selection of potential lung cancer biomarkers.
Ligor T; Pater Ł; Buszewski B
J Breath Res; 2015 May; 9(2):027106. PubMed ID: 25944812
[TBL] [Abstract][Full Text] [Related]
27. Breath gas aldehydes as biomarkers of lung cancer.
Fuchs P; Loeseken C; Schubert JK; Miekisch W
Int J Cancer; 2010 Jun; 126(11):2663-70. PubMed ID: 19839051
[TBL] [Abstract][Full Text] [Related]
28. Variation in volatile organic compounds in the breath of normal humans.
Phillips M; Herrera J; Krishnan S; Zain M; Greenberg J; Cataneo RN
J Chromatogr B Biomed Sci Appl; 1999 Jun; 729(1-2):75-88. PubMed ID: 10410929
[TBL] [Abstract][Full Text] [Related]
29. Detection of volatile biomarkers of therapeutic radiation in breath.
Phillips M; Byrnes R; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mehta V; Mundada M; Patel U; Ramakrishna N; Schiff PB; Zhang X
J Breath Res; 2013 Sep; 7(3):036002. PubMed ID: 23793046
[TBL] [Abstract][Full Text] [Related]
30. Detection of lung cancer using weighted digital analysis of breath biomarkers.
Phillips M; Altorki N; Austin JH; Cameron RB; Cataneo RN; Kloss R; Maxfield RA; Munawar MI; Pass HI; Rashid A; Rom WN; Schmitt P; Wai J
Clin Chim Acta; 2008 Jul; 393(2):76-84. PubMed ID: 18420034
[TBL] [Abstract][Full Text] [Related]
31. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.
Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415
[TBL] [Abstract][Full Text] [Related]
32. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics.
Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K
Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139
[TBL] [Abstract][Full Text] [Related]
33. Breath biomarkers of active pulmonary tuberculosis.
Phillips M; Basa-Dalay V; Bothamley G; Cataneo RN; Lam PK; Natividad MP; Schmitt P; Wai J
Tuberculosis (Edinb); 2010 Mar; 90(2):145-51. PubMed ID: 20189456
[TBL] [Abstract][Full Text] [Related]
34. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
[TBL] [Abstract][Full Text] [Related]
35. Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry.
Phillips M; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mundada M; Patel U; Zhang X
PLoS One; 2013; 8(9):e75274. PubMed ID: 24086492
[TBL] [Abstract][Full Text] [Related]
36. Effect of oxygen on breath markers of oxidative stress.
Phillips M; Cataneo RN; Greenberg J; Grodman R; Gunawardena R; Naidu A
Eur Respir J; 2003 Jan; 21(1):48-51. PubMed ID: 12570108
[TBL] [Abstract][Full Text] [Related]
37. Method for the collection and assay of volatile organic compounds in breath.
Phillips M
Anal Biochem; 1997 May; 247(2):272-8. PubMed ID: 9177688
[TBL] [Abstract][Full Text] [Related]
38. High sensitivity for lung cancer detection using analysis of exhaled carbonyl compounds.
Schumer EM; Trivedi JR; van Berkel V; Black MC; Li M; Fu XA; Bousamra M
J Thorac Cardiovasc Surg; 2015 Dec; 150(6):1517-22; discussion 1522-4. PubMed ID: 26412316
[TBL] [Abstract][Full Text] [Related]
39. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
40. Temperature-programmed gas chromatography linear retention indices of all C4-C30 monomethylalkanes on methylsilicone OV-1 stationary phase. Contribution towards a better understanding of volatile organic compounds in exhaled breath.
Krkosová Z; Kubinec R; Soják L; Amann A
J Chromatogr A; 2008 Jan; 1179(1):59-68. PubMed ID: 18021789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
